Literature DB >> 17870543

Synthesis and antibacterial activity of pyranmycin derivatives with N-1 and O-6 modifications.

Jie Li1, Fang-I Chiang, Hsiao-Nung Chen, Cheng-Wei Tom Chang.   

Abstract

Continuing from our ongoing effort in modifying aminoglycoside antibiotics with the goal of counteracting drug resistant bacteria, we have further derivatized pyranmycin, a neomycin class aminoglycoside antibiotic, with modifications at O-6 and N-1 positions. The revealed SAR results demonstrated that the antibacterial activity of pyranmycin can be modulated by different acylic substituents at O-6. Among these results, the 6-O-aminoethyl derivative, JT050, showed effective activity against resistant strain Escherichia coli (pTZ19U-3) and E. coli (pSF815), which provides insight into further structural modifications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17870543      PMCID: PMC2692305          DOI: 10.1016/j.bmc.2007.08.059

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

Review 1.  Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance.

Authors:  L P Kotra; J Haddad; S Mobashery
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 2.  Aminoglycosides: activity and resistance.

Authors:  M P Mingeot-Leclercq; Y Glupczynski; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

3.  Pyranmycins, a novel class of aminoglycosides with improved acid stability: the SAR of D-pyranoses on ring III of pyranmycin.

Authors:  Cheng-Wei Tom Chang; Yu Hui; Bryan Elchert; Jinhua Wang; Jie Li; Ravi Rai
Journal:  Org Lett       Date:  2002-12-26       Impact factor: 6.005

4.  Design of novel antibiotics that bind to the ribosomal acyltransfer site.

Authors:  Jalal Haddad; Lakshmi P Kotra; Beatriz Llano-Sotelo; Choonkeun Kim; Eduardo F Azucena; Meizheng Liu; Sergei B Vakulenko; Christine S Chow; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2002-04-03       Impact factor: 15.419

5.  Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry.

Authors:  Desiree H Fong; Albert M Berghuis
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

6.  Synthesis and antibacterial activity of novel neamine derivatives.

Authors:  Nobuto Minowa; Yoshihisa Akiyama; Yukiko Hiraiwa; Kazunori Maebashi; Takayuki Usui; Daishiro Ikeda
Journal:  Bioorg Med Chem Lett       Date:  2006-09-25       Impact factor: 2.823

7.  Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA.

Authors:  D Fourmy; M I Recht; J D Puglisi
Journal:  J Mol Biol       Date:  1998-03-27       Impact factor: 5.469

8.  Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic.

Authors:  D Fourmy; M I Recht; S C Blanchard; J D Puglisi
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

9.  The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography.

Authors:  Rupert J M Russell; James B Murray; Georg Lentzen; Jalal Haddad; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2003-03-26       Impact factor: 15.419

Review 10.  Versatility of aminoglycosides and prospects for their future.

Authors:  Sergei B Vakulenko; Shahriar Mobashery
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more
  2 in total

1.  A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2015-11-19       Impact factor: 3.597

Review 2.  Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Chem Soc Rev       Date:  2018-02-19       Impact factor: 54.564

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.